Key Insights

Highlights

Success Rate

84% trial completion

Published Results

11 trials with published results (13%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.2%

8 terminated out of 87 trials

Success Rate

84.0%

-2.5% vs benchmark

Late-Stage Pipeline

13%

11 trials in Phase 3/4

Results Transparency

26%

11 of 42 completed with results

Key Signals

11 with results84% success

Data Visualizations

Phase Distribution

61Total
Not Applicable (36)
P 1 (6)
P 2 (8)
P 3 (3)
P 4 (8)

Trial Status

Completed42
Unknown20
Recruiting12
Terminated8
Not Yet Recruiting3
Active Not Recruiting2

Trial Success Rate

84.0%

Benchmark: 86.5%

Based on 42 completed trials

Clinical Trials (87)

Showing 20 of 20 trials
NCT04238260Not ApplicableCompleted

Enhancing Physical Therapy Best Practice for Improving Walking After Stroke

NCT07628283Not ApplicableNot Yet Recruiting

A Cluster Randomized Trial of a Telemedicine-Enabled Integrated Care Model for Stroke Prevention and Management in Rural Elderly Adults in China

NCT03684564Phase 2Completed

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

NCT04001049CompletedPrimary

Glycemic Variability: Prognostic Impact on Acute Ischemic Stroke

NCT06270927Active Not RecruitingPrimary

A Feasibility Study for Randomization of Code Stroke Imaging Strategies

NCT00590980Completed

Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)

NCT07526649Not ApplicableNot Yet Recruiting

Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b)

NCT04992195Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

NCT03592563Recruiting

CUHK Brain Health Longitudinal Study

NCT00147316Phase 3Completed

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

NCT06954610Recruiting

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

NCT06081283Phase 4Terminated

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

NCT04941482Not ApplicableCompleted

Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients.

NCT07181564Not ApplicableRecruiting

Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension

NCT06121336Recruiting

PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke

NCT07069452Recruiting

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

NCT03962127Active Not Recruiting

MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

NCT06873477Recruiting

Evaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury

NCT04981184Not ApplicableRecruitingPrimary

Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke

NCT06409806Not ApplicableRecruiting

Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)

Scroll to load more

Research Network

Activity Timeline